MARGARET RABBITT: Open Payments
NPI 1891139606 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,724 in 33 payments from 13 companies in 2025. Trend: 2023 $1,282 · 2024 $1,507 · 2025 $1,724
Food & beverage: $1,724
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $513 |
| GlaxoSmithKline, LLC. | 8 | $339 |
| GENZYME CORPORATION | 2 | $236 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $181 |
| Regeneron Healthcare Solutions, Inc. | 1 | $123 |
| Gilead Sciences, Inc. | 1 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Lilly USA, LLC | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Soleno Therapeutics, Inc. | 1 | $15 |
Products named: DUPIXENT, AIRSUPRA, Kerendia, BREZTRI, Epclusa, TEZSPIRE, AREXVY, PENMENVY.
Industry payments across OH — which companies pay providers there.
